27 participants
Study for Late Assessment of the Safety and Efficacy of Biosimilar Rituximab
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2023-10-12
- Start Date:
- 2022-02-08
- Completion:
- 2022-07-29
Conditions
- Diffuse Large B Cell Lymphoma
No Results Yet